82864-25-3

Usage

Uses

Used in Pharmaceutical Industry:
Ethyl L-octahydroindole-2-carboxylate hydrochloride is used as a key intermediate in the synthesis of various pharmaceutical drugs. Its unique chemical structure and properties make it a versatile building block for the development of new therapeutic agents.
Used in Neurological and Psychiatric Disorders Treatment:
Ethyl L-octahydroindole-2-carboxylate hydrochloride is used as a potential therapeutic agent for the treatment of various neurological and psychiatric disorders. Its ability to modulate neurotransmitter activity in the brain makes it a promising candidate for the development of drugs targeting conditions such as depression, anxiety, and other mood disorders.
Used in Organic Chemistry Research:
Ethyl L-octahydroindole-2-carboxylate hydrochloride is used as a research tool in the field of organic chemistry. Its unique chemical properties and reactivity make it an interesting subject for studying various organic reactions and mechanisms.
Used in Drug Development:
Ethyl L-octahydroindole-2-carboxylate hydrochloride is used in drug development as a starting material or a building block for the synthesis of new drug candidates. Its potential therapeutic applications in various disorders make it a valuable asset in the search for novel and effective treatments.

InChI:InChI=1/C11H19NO2.ClH/c1-2-14-11(13)10-7-8-5-3-4-6-9(8)12-10;/h8-10,12H,2-7H2,1H3;1H/t8-,9-,10-;/m0./s1

Upstream product

• 79815-20-6 (S)-indoline-2-carboxylic acid 
• 79854-42-5 Ethyl (S)-indoline-2-carboxylate hydrochloride 

Downstream Products

• 127413-73-4 (2S,3aS,7aS)-1-(N-benzyloxycarbonyl-L-histidyl-γ-D-glutamyl)-octahydro-1H-indole-2-carboxylic acid 
• 127413-82-5 (2S,3aS,7aS)-1-{(R)-4-[(S)-2-Benzyloxycarbonylamino-3-(1H-imidazol-4-yl)-propionylamino]-4-ethoxycarbonyl-butyryl}-octahydro-indole-2-carboxylic acid ethyl ester 
• 126110-69-8 (2S,3aS,7aS)-1-{(S)-6-Benzyloxycarbonylamino-2-[hydroxy-(4-phenyl-butyl)-phosphinoyloxy]-hexanoyl}-octahydro-indole-2-carboxylic acid ethyl ester 
• 126110-40-5 (2S,3aS,7aS)-1-{(S)-6-Amino-2-[hydroxy-(4-phenyl-butyl)-phosphinoyloxy]-hexanoyl}-octahydro-indole-2-carboxylic acid 
• 145513-54-8 1-<(2S) 2-<((1S) 1-carbethoxybutyl) amino> 1-oxo propyl> (2S, 3aS, 7aS) perhydroindole 2-carboxylic acid 
• 107133-36-8 perindopril erbumine 
• 107045-53-4 (2S,3aS,7aS)-1-(benzyloxycarbonyl)octahydro-1H-indole-2-carboxylic acid 
• 80876-00-2 (2α,3aβ,7aβ)-octahydro-1H-indole-2-carboxylic acid tert-butyl ester 
• 80875-98-5 (2S,3aS,7aS)-perhydroindole-2-carboxylic acid 
• 119741-18-3 (2S,3aS,7aS)-1-((R)-4-Benzyloxycarbonylamino-4-ethoxycarbonyl-butyryl)-octahydro-indole-2-carboxylic acid ethyl ester 
• 126110-92-7 (2S,3aS,7aS)-1-((S)-6-Benzyloxycarbonylamino-2-hydroxy-hexanoyl)-octahydro-indole-2-carboxylic acid ethyl ester 

Relevant academic research and scientific papers

Phosphonate substituted amino acids useful as antihypertensives

Hypotensive activity is exhibited by new phosphonate substituted amino or imino acids of the formula STR1 isomeric mixtures thereof and pharmaceutically acceptable salts thereof, wherein: X is an imino or amino acid of the formula STR2